Jacobo Rogado Revuelta

19PUBLICATIONS
105CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Major global burdens of diseasePacific Peoples and disability
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Sep 24, 2026
Body Mass Index and Body Fat Percentage Are Associated with Clinical Outcomes in Patients Receiving PD-1/PD-L1 Inhibitors: A Prospective Exploratory Study.

|Sep 17, 2026
Longitudinal Clinical, Physiological, and Molecular Profiling of Female Patients With Metastatic Cancer: Protocol and Feasibility of a Multicenter High-Definition Oncology Study.

|Jul 13, 2026
Toward a Better Paradigm for Head and Neck Cancer Treatment Applying AI (HNC-TACTIC): Protocol for an International Cohort Study of Electronic Health Records.

|Oct 28, 2025
Chemokine Receptors in Peripheral Blood Mononuclear Cells as Predictive Biomarkers for Immunotherapy Efficacy in Non-Small Cell Lung Cancer.

Paloma Galera, Antía Iglesias-Beiroa, Berta Hernández-Marín

|Dec 21, 2024
The role of the CXCL12/CXCR4 axis in the immunotherapy of non-small cell lung cancer.

Jacobo Rogado, Fernando Pozo, Kevin Troule

|Aug 07, 2024
SEOM clinical guidelines on venous thromboembolism (VTE) and cancer (2023).

Laura Ortega Morán, Francisco José Pelegrín Mateo, Rut Porta Balanyà

Pageof 4

Frequent Collaborators

8 joint publications

Caterina Calderon

8 joint publications

Paula Jimenez-Fonseca

6 joint publications

Ana Fernández-Montes

6 joint publications

Raquel Hernández-San Gil